West Virginia's settlement two years ago with Purdue Pharma, maker of the drug Oxycontin, was alarming on numerous grounds; Prof. Childs, pointing to this student note (PDF) by Joseph B. Prater of Northwestern on the affair, observes that the case was "another step in efforts to make products liability cases into public nuisance cases". Guns and lead paint having already been assailed under nuisance theories, he wonders whether other pharmaceuticals will follow.
Oxycontin and nuisance
![]() |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
![]() |
| Bridget Carroll Press Officer, Manhattan Institute bcarroll@manhattan-institute.org |



